Login / Signup

Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia.

Yingying ZhangJiechuan RenTianhua YangWeixi XiongLinyuan QinDongmei AnFayun HuDong Zhou
Published in: Therapeutic advances in neurological disorders (2024)
variants. Carbamazepine and oxcarbazepine are both used as a first-line treatment choice for PKD patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • copy number
  • prognostic factors
  • genome wide
  • gene expression
  • patient reported